Topal A, Başak M. Evaluating the role of HER2-low versus HER2-0 status in predicting response to neoadjuvant chemotherapy in hormone receptor-positive breast cancer. Eur Res J [Internet]. 2025 Sep. 3 [cited 2026 Apr. 5];11(5):858-67. Available from: https://eurj.org.tr/article/view/1042